[go: up one dir, main page]

EP1556127A2 - Stimulation electrique du cerveau - Google Patents

Stimulation electrique du cerveau

Info

Publication number
EP1556127A2
EP1556127A2 EP03777727A EP03777727A EP1556127A2 EP 1556127 A2 EP1556127 A2 EP 1556127A2 EP 03777727 A EP03777727 A EP 03777727A EP 03777727 A EP03777727 A EP 03777727A EP 1556127 A2 EP1556127 A2 EP 1556127A2
Authority
EP
European Patent Office
Prior art keywords
white matter
brain structure
stimulation
electrical
stimulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03777727A
Other languages
German (de)
English (en)
Inventor
Jurgen Luders
Imad Najm
Hans O. Luders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cleveland Clinic Foundation
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Publication of EP1556127A2 publication Critical patent/EP1556127A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0529—Electrodes for brain stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0529—Electrodes for brain stimulation
    • A61N1/0531—Brain cortex electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0529—Electrodes for brain stimulation
    • A61N1/0534—Electrodes for deep brain stimulation

Definitions

  • the present invention relates to treatment for the nervous system, and more particularly to systems and methods for electrically stimulating the brain.
  • electrical stimulation can provide an effective treatment for patients when surgical lesioning of brain tissue is not a suitable option as well as when patients are not sufficiently responsive to other treatment modalities, such as drug therapy.
  • Some different types of electrical stimulation treatments include vagal nerve stimulation, cerebellar stimulation, and deep brain stimulation.
  • One major advantage of electrical stimulation over lesioning procedures e.g., pallidotomy and thalamotomy
  • the electrical stimulation can be reversible and adjustable.
  • brain stimulation can be implemented with no destruction of brain tissue and the stimulator can be removed, if needed.
  • the stimulation can be adjusted (e.g., increased, minimized or turned off or otherwise modified) to achieve better clinical effects for each patient.
  • Vagal nerve stimulation is one accepted type of treatment for epilepsy and Parkinson's disease. Vagal nerve stimulation is typically performed via a stimulator device, which includes a generator that electrically stimulates the brain through the vagus nerve to prevent seizures.
  • the generator is surgically implanted into the chest, such as under the collarbone, and can be activated automatically or manually, such as by passing a magnet over the device.
  • STN subthalamic nucleus
  • the present invention relates to electrical stimulation of white matter tracts in the brain to mitigate or help control seizures.
  • One or more stimulators or electrodes can be positioned to electrically stimulate a white matter tract to enable stimulation of an associated epileptogenic focus or zone.
  • the particular white matter structure to which the stimulation is applied can vary based on the location of the epileptogenic zone.
  • electrical stimulation can be applied to the fornix, such as where the epileptic zone has been determined to include the hippocampus.
  • electrical stimulation can be applied to the corpus callosum, such as where the epileptic zone has been determined to be cortical.
  • the stimulator can include a generally annular or C-shaped body that can circumscribe at least a portion of the desired white matter, such as the body of the fornix, which is associated with the epileptogenic zone.
  • the body portion includes one or more electrodes that can electrically stimulate the desired white matter when implanted.
  • the stimulator can be implanted into the white matter itself.
  • the stimulator is adapted to receive an electrical signal from a signal generator for stimulating the white matter in a desired matter.
  • the signal generator can be programmable.
  • endoscopic means can be efficiently utilized to associate the stimulator with desired white matter in accordance with an aspect of the present invention.
  • FIG. 1 is a block diagram illustrating a brain stimulation system in accordance with an aspect of the present invention.
  • FIG. 2 is an example of one type of brain stimulation system for stimulating the fornix in accordance with an aspect of the present invention.
  • FIG. 3 is another view of a brain stimulator located for stimulating the fornix associated with an epileptogenic structure in accordance with an aspect of the present invention.
  • FIG. 3 A depicts some neurological pathways associated with the hippocampus and fornix that can be employed in stimulation in accordance with an aspect of the present invention.
  • FIG. 4 is an example of a stimulator device in accordance with an aspect of the present invention.
  • FIG. 5 is an example of another type of brain stimulation system for stimulating the fornix in accordance with an aspect of the present invention.
  • FIG. 6 is an example of one type of brain stimulation system for stimulating the corpus callosum in accordance with an aspect of the present invention.
  • FIG. 7 is a coronal section of the brain illustrating corpus callosum stimulation in accordance with an aspect of the present invention.
  • FIG. 8 is an example of another type of brain stimulation system for stimulating the corpus callosum in accordance with an aspect of the present invention.
  • FIG. 9 is a flow diagram illustrating a methodology for brain stimulation in accordance with an aspect of the present invention. Detailed Description of the Invention
  • the present invention relates electrical stimulation of structures having high fiber density, such as white matter tracts, to effect desired stimulation of associated epileptogenic structures.
  • the stimulation of such white matter tracts or other structures can help reduce seizures or otherwise help control seizures by electrically overdriving the associated epileptogenic structures.
  • FIG. 1 depicts a schematic example of a brain stimulation system 10 in accordance with an aspect of the present invention.
  • the system 10 includes a stimulator 12 electrically associated with a white matter tract 14 of a patient's brain 16.
  • White matter is generally formed of nerve fibers, called axons, which are insulated by a fatty substance known as myelin.
  • White matter carries information between nerve cells of associated non- white matter brain structures by conducting electrical impulses through the nerve fibers.
  • the stimulator 12 can be configured as an elongated rod, a depth electrode, a ring, a clamp, or other devices capable of providing desired electrical stimulation to the white matter 14.
  • the stimulator 12 can be self-contained and include a signal generator or, alternatively, it may receive electrical signals from a control system 18.
  • the stimulator 12 can be collapsible or otherwise deformable to facilitate endoscopic implantation of the stimulator.
  • a control system 18 is operative to control operation of the stimulator 12, such as by providing a signal to the stimulator for electrically stimulating the white matter tract 14 based on the signal.
  • the control system 18 can be coupled to the stimulator 12 through an electrically conductive element, which provides an electrical signal having desired electrical characteristics.
  • the control system 18 can be configured to activate the stimulator via wireless means, such as electromagnetic fields (e.g., radio frequency (RF)), magnetic fields and the like to provide desired stimulation. That is, a direct connection between the control system 18 and the stimulator 12 is not required.
  • RF radio frequency
  • the control system 18 can include a signal generator 20 programmed and/or configured to activate the stimulator for white matter stimulation at a desired intensity (e.g., amperage) and frequency over a predetermined time period.
  • the signal generator can provide electrical pulses at a frequency ranging from about 0.1 Hz to about 5000 Hz. It has been determined some patient's may respond better to low frequency stimulation, such as at a frequency less than about 10 Hz (e.g., in a range from about 0.5 Hz to about 4 Hz).
  • the duty cycle (or pulse width) of such pulses also can be programmable.
  • the amplitude of electrical current also may vary based at least in part on the patient's condition and the white matter 14 structure to which the stimulator is positioned.
  • the signal generator 20 can be configured to provide electrical current having an amplitude in a range from 0 to about 5 mA, which can be a monophase or polyphase signal.
  • the stimulator 12 is positioned (e.g., by stereotaxis or endoscopy) relative to the white matter tract 14 to enable desired electrical stimulation of a corresponding epileptogenic focus in response to activation of the stimulator.
  • the white matter 14 is fibrous connection that provides an electrical pathway between the stimulator 12 and the corresponding epileptogenic focus.
  • the stimulator 12 can be positioned adjacent to, in contact with or within a selected white matter structure 12. Where more than one epileptogenic focus exists, multiple stimulators can be utilized to stimulate white matter structures associated with each respective focus in accordance with an aspect of the present invention.
  • stimulators can be used unilaterally, such as where a focus exists only in a single hemisphere of the brain 16, or bilaterally, such as where foci exist in both hemispheres.
  • Various diagnostic techniques can be utilized, individually or in combination, to determine the location of one or more epileptogenic foci (or zones) for a patient. Some examples include electroencephalography (EEG), magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), magnetoencephalography (MEG), magnetic resonance spectroscopy (MRS), depth electrode and subdural grid implantation, video monitoring, neuropsychological testing and so forth.
  • EEG electroencephalography
  • MRI magnetic resonance imaging
  • PET positron emission tomography
  • SPECT single photon emission computed tomography
  • MRS magnetic resonance spectroscopy
  • depth electrode and subdural grid implantation video monitoring, neuropsychological testing and so forth.
  • some epileptogenic structures include the hippocampus and neocortical structures.
  • the stimulator 12 can be positioned to stimulate these and other epileptogenic structures by direct electrical stimulation of corresponding white matter tracts, at least a portion of which are connected to such epileptogenic structures.
  • fornix stimulation can be utilized in the case of epileptoid convulsions originating in the hippocampus.
  • the fornix is the white matter tract that is a major output pathway of each hippocampal formation, connecting it to the frontal lobe, and parts of thalamus and hypothalamus.
  • Stimulation of the corpus callosum for example, can be employed for stimulating neocortical areas.
  • the corpus callosum comprises the white matter bundles which collectively serve to interconnect cortical areas in the two cerebral hemispheres of the brain 16.
  • white matter tracts e.g., the temporal stem
  • other white matter tracts e.g., the temporal stem
  • one or more stimulators can be used to stimulate appropriate white matter, such as unilaterally or bilaterally, depending on the epileptogenic zone or zones.
  • the brain stimulation system 10 can be implemented as a closed loop system in which the control system 18 is operative to activate the stimulator 12 in response a sensed characteristic of the brain 16.
  • the control system 18 is operative to activate the stimulator 12 in response a sensed characteristic of the brain 16.
  • one or more sensors 22 can be used to sense electrical activity associated with the onset of a seizure or other neurological condition.
  • the sensors 22 can be subdural or external probes located at or near the determined epileptogenic zones.
  • the stimulator 12 itself can be configured to operate as a sensor and provide signals to the control system 18 indicative of seizure onset.
  • the control system 18 thus can control the signal generator 20 to operate the stimulator 12 to provide stimulation as a function of sensed electrical (or chemical) activity of the brain 16.
  • the stimulation can include electrical current having an amplitude, frequency and pulse width, some or all of which can vary based on the sensed characteristic(s).
  • electrical current having an amplitude, frequency and pulse width, some or all of which can vary based on the sensed characteristic(s).
  • sensors and detection software that can be utilized to detect seizure onset, all of which can be employed to control stimulation in accordance with an aspect of the present invention.
  • FIG. 2 is an example of an electrical stimulation system 50 implemented to stimulate the fornix 52 in accordance with an aspect of the present invention.
  • the system 50 includes a stimulator 54 that is positioned at or around at least part of the body of the fornix 52, such as for corresponding hippocampal stimulation.
  • the stimulator 54 can include one or more electrodes that contact the fornix 52 for providing electrical stimulation according to electrical signals from an associated electrical signal generator 56.
  • Such a stimulator 54 electrode can be implemented as a depth electrode or it can be attached to a support, which can be a clamp, pronged adaptor, or frame configured for relatively secure attachment to the fornix (See, e.g., FIG. 4).
  • the stimulator position for the fornix 52 may vary from patient to patient as well as based on the determined location of the epileptogenic focus.
  • the stimulator 54 can be positioned stereotactically or endoscopically. Endoscopy is particularly useful for positioning the stimulator at the fornix, as the fornix is accessible through corresponding lateral ventricles. Endoscopy thus facilitates implantation of the stimulator 54 aided by its visual component.
  • the signal generator 56 can be programmable to control operation of the stimulator 54 in a desired manner.
  • the signal generator 56 can be programmed to activate the stimulator 54 intermittently or periodically to provide electrical current to the fornix 52 at a desired intensity (e.g., amperage), frequency, and duty cycle over a predetermined time period.
  • the signal generator 56 can form part of a closed loop system that includes a controller operative to activate the stimulator 54 in response to sensing onset of a seizure or other neurological disorders.
  • a system can employ one or more other sensors (e.g., subdural probes) located at or near the determined epileptogenic zones.
  • FIG. 3 depicts another example of fornix stimulation in accordance with an aspect of the present invention.
  • an annular stimulator 72 has been implanted around part of the fornix 74, such as at the fornix body spaced apart from the hippocampus 76.
  • the fornix 74 includes numerous neuron fibers, schematically represented at 78.
  • the fornix fibers 78 which includes fibers for both orthodromic and antidromic impulses, connect the hippocampus 76 with the hyphothalamus (not shown). Such fibers also form part of the circuit of Papez. Because the fornix fibers 78 connect to the hippocampus 76, such fibers provide an efficient electrical pathway for transferring electrical stimulation from the fornix 74 to the hippocampus 76.
  • the enlarged part of FIG. 3 further diagrammatically represents the transfer of electrical signals at the juncture between the crura of fornix 80 to the fimbria of hippocampus 82, which hippocampal stimulation varies based on the fornix stimulation.
  • FIG. 3A is schematic representation of the major information pathways in the hippocampal region 86 and their relationship with the fornix 87.
  • the perforant pathway 88 carries output from the superficial entorhinal cortex 89, which forms the input to the hippocampus and is responsible for the pre-processing of input signals.
  • the perforant pathways 88 carry signals from the entorhinal cortex 89 to the dentate gyrus 90, and information travels thence to fields CA1-CA4, the subiculum 91, and back to the deep layers of the entorhinal cortex, which, in turn, sends output back to the sensory association areas.
  • Efferents 94 from the subiculum 91 are also associated with the fornix 87.
  • Afferents 95 from the fornix 87 also are shown as terminating in the mossy fibers 96 of the dentate gyrus 90.
  • the mossy fibers 96 branch profusely in white matter structures, each branch having multiple swellings that contain round vesicles and synaptic thickenings.
  • Basket cells 97 further are illustrated, which inhibit the piriform neurons, which, in turn, neurons inhibit the deep nuclei and the vestibular nuclei on which their axons synapse.
  • FIG. 4 illustrates an example of a stimulator device 100 in accordance with an aspect of the present invention.
  • the device 100 includes a generally elongated body portion 102 dimensioned and configured for attaching to desired white matter structure.
  • the body portion 102 is depicted as a generally cylindrical portion having an inner sidewall portion 104 configured for attachment to white matter, such as the fornix 106.
  • the body portion 102 also can be deformable to a reduced cross-sectional dimension, such as to facilitate its implantation and positioning around the fornix 106.
  • the body portion 102 can be formed of a substantially resilient flexible material that can be urged into a tubular structure, such as for implantation via endoscopy.
  • the stimulator device 100 can be inserted into an endoscope (not shown) for implantation through a small cranial burr-hole.
  • a distal end of the endoscope can be guided through a ventricle (e.g. s right or left lateral ventricles) so as to facilitate positioning the device 100 around the corresponding fornix 106.
  • the device has a reduced cross- sectional dimension to facilitate its implantation.
  • the device 100 can be expanded to its expanded dimension (e.g., spring activated, urged open by balloon catheterization) for attachment to the fornix 106, such as depicted in FIG. 4.
  • its expanded dimension e.g., spring activated, urged open by balloon catheterization
  • One or more electrodes 108 and 110 are disposed along the body portion 102 for providing electrical current to the fornix 106. While two electrodes are shown in
  • the electrodes 108 and 110 can be mounted to the interior sidewall 104 or be otherwise attached thereto.
  • the electrodes 108 and 110 are electrically coupled to receive corresponding electrical signals from one or more sources of electrical energy, such as a signal generator (not shown).
  • electrical conductors 112 can extend from the electrodes 108, 110 to within a base plate 116 and through an insulating structure 118, such as a tube formed of an insulating material.
  • the plate 116 can be attached to the body portion 102 or it can be formed integrally with the body portion.
  • the plate 116 and tube 116 can be formed of the same or different material. Additionally or alternatively, the body portion 102 can be formed of the same or a different material from the base plate 116. Those skilled in the art will understand and appreciate various types of materials that can be used to form the various parts of the device 100 based on the above description, all of which are contemplated as falling within the spirit and scope of the present invention.
  • FIG. 5 is an example of another electrical stimulation system 130 that can be employed for fornix 132 stimulation in accordance with an aspect of the present invention.
  • the system 130 includes a stimulator 134 that is located at or near an end 136 of an elongated rod 138.
  • the rod 138 is inserted into the brain 140 in a minimally invasive manner to position the stimulator 134 in contact with, inside or near the fornix 132.
  • fornix stimulation can effectively treat epileptogenic zones in the hippocampus by overdriving electrical activity at hippocampal epileptic zones electrically associated with the fornix (e.g., connected by fornix neural fibers).
  • the location of the stimulator 134 relative to the fornix 132 may depend, for example, on the location of the epileptogenic focus, seizure frequency and severity or other patient specific parameters.
  • the stimulator 134 can include one or more electrodes located at the or near the end 136 of the rod 138, which electrodes are operative to provide electrical stimulation according to electrical signals provided by an associated electrical signal generator 142.
  • the signal generator 142 can be programmed and configured to provide electrical signals (e.g., pulses having desired electrical characteristics, such as described hereinabove) to the stimulator 134 for electrically stimulating the fornix 132.
  • electrical signals e.g., pulses having desired electrical characteristics, such as described hereinabove
  • the electrical stimulation can be implemented as a predetermined schedule (e.g., open loop configuration) or based on one or more sensed conditions (e.g., closed loop configuration).
  • FIG. 6 illustrates an example of corpus callosal stimulation in accordance with an aspect of the present invention.
  • the type of stimulation system 150 being utilized is similar to that described above with respect to FIG. 5.
  • the system 150 includes a stimulator 152 that is located at or near an end 154 of an elongated rod 156.
  • the rod is inserted into the brain 158 in a minimally invasive manner to position the stimulator 152 in electrical contact with the corpus callosum 160.
  • the stimulator 152 includes one or more electrodes, which are operative to provide electrical stimulation according to electrical signals provided by an associated electrical signal generator 157.
  • electrical stimulation of the corpus callosum 160 can effectively treat epileptogenic zones in the neocortical areas by overdriving electrical activity at such epileptic zones.
  • the corpus callosum 160 is white matter that connects significant regions of the two hemispheres of the brain 158.
  • the corpus callosum 160 includes numerous commissual fibers, specific parts of which intercomiect the corpus callosum with corresponding regions of cortex.
  • Various parts of the corpus callosum 160 include the rostrum 162, genu 164, body or trunk 166, and splenium 168.
  • fibers in the splenium 168 interconnect the occipital and posterior temporal cortices on the two sides of the brain 158.
  • FIG. 7 depicts a coronal section of a brain 170 illustrating white matter fibrous interconnections 172 from the corpus callosum 174 to electrically associated neocortical areas.
  • neocortical areas can be effectively electrically stimulated (e.g., overdriven), such as those detennined to be epileptogenic zones.
  • FIG. 8 depicts another type of stimulator system 200 that can be utilized to electrically stimulate the corpus callosum 202 in accordance with an aspect of the present invention.
  • the system 200 includes a stimulator device 204, which in this example is depicted as an implantable electrode device.
  • One or more of such stimulator devices 204 are positioned in electrical contact with selected parts of the corpus callosum 202 associated with cortical areas that have been determined to be epileptogenic zones. Any one or more of the diagnostic modalities mentioned herein above can be employed to ascertain the location of epileptogenic zone or zones for a given patient.
  • the stimulator device 204 can be implanted in the brain 210 using open craniotomy, stereotactic or endoscopic means, for example.
  • the stimulator device 204 is coupled to a signal generator 212 that is operative to provide electrical signal to the stimulator having desired electrical characteristics, such as described herein.
  • the signal generator 212 can be configured to operate in an open loop manner, thereby providing the electrical signals according to a preprogrammed pulse modulation scheme.
  • the signal generator can operate in a closed loop manner, such as by generating electrical signal based on one or more sensed conditions. Such sensed conditions can be associated with the epileptogenic zones, for example, signals from sensors indicative of seizure onset.
  • sensed conditions can be associated with the epileptogenic zones, for example, signals from sensors indicative of seizure onset.
  • FIG. 9 a methodology for implementing electrical stimulation of white matter tracts, in accordance with an aspect of the present invention, will be better appreciated with reference to FIG. 9.
  • Those skilled in the art will understand and appreciate that not all illustrated features may be required to implement a methodology in accordance with an aspect of the present invention. While, for purposes of simplicity of explanation, the methodology of FIG. 9 is shown and described as being implemented serially, it is to be understood and appreciated that the present invention is not limited to the illustrated order, as some parts of the methodology could, in accordance with the present invention, occur in different orders or concurrently with other parts from that shown and described.
  • Various parts of the methodology can be implemented as computer executable instructions running in a computer or other microprocessor based device (e.g., a signal generator or other associated control system).
  • the methodology can be performed for patients that have seizures which are intractable to standard treatments such as various anti-epileptic medications.
  • the methodology begins at 300 in which the location of one or more epileptogenic foci is determined. This determination can be made based on one or a combination of diagnostic modalities, such as mentioned above.
  • corresponding white matter associated with or otherwise connected with the epileptogenic focus of foci are located. Such locations can define implantation sites for one or more stimulators according to an aspect of the present invention. For example, the fornix can be used if the epileptogenic focus has been determined to be the hippocampus and the corpus callosum can be used for stimulation if the epileptogenic focus has been determined to be neocortical.
  • the implant site can be further selected based on various patient specific parameters, such as mentioned above.
  • Stimulators can be implanted unilaterally or bilaterally depending on the epileptogenic focus or foci.
  • a stimulator or stimulators is implanted for electrically stimulating the white matter determined at 310.
  • the stimulator can be implanted stereotactically or endoscopically depending generally on the implant site and type of stimulator(s) being used.
  • electrical stimulation characteristics are determined.
  • the electrical characteristics (e.g., as noted above) generally will vary depending on whether the system is being implemented as an open or closed loop system, a variety or patient specific indications as well as the proximity and electrical pathways interconnecting the white matter and the predetermined epileptogenic zone(s).
  • the stimulation system e.g. t signal generator, controls
  • the signal generator can be configured to provide electrical pulses to one or more electrodes of the stimulator at a frequency ranging from about 0.1 Hz to about 5000 Hz.
  • low frequency such as less than about 10 Hz (e.g., in a range from about 0.5 Hz to about 4 Hz) can also be employed.
  • the duty cycle of the electrical pulses also can be programmable.
  • the amplitude of electrical current can be set based at least in part on the patient's condition and the white matter structure being stimulated for overdriving the epileptogenic focus.
  • Electrical current pulses can be provided having an amplitude in a range from 0 to about 5 mA, which pulses can be monophasic or polyphasic signals, for example.
  • Normal operation can begin at 350.
  • electrical stimulation of the white matter tract results in indirect electrical stimulation of the determined epileptogenic zone via the electrical pathway provided by the white matter structure fibrously connected with the zone.
  • the adjustments can be based on empirical studies and other data (e.g., patient-specific data or aggregate data collected from a group of patients). Those skilled in the art will understand and appreciate that such adjustments also can be implemented in real time, such as part of the closed loop control process based on feedback from one or more sensors (e.g., intra-cranial or external). The adjustments can also include stopping stimulations for an extended period of time or indefinitely, if deemed appropriate.
  • Appendix A which forms an integral part of the subject application, includes additional information related to brain stimulation in accordance with one or more aspects of the present invention.
  • brain stimulation according to an aspect of the present invention can be combined with other treatment modalities (e.g., chemical stimulation, drug therapy).
  • other treatment modalities e.g., chemical stimulation, drug therapy
  • comiections to the stimulator could include means for administering chemicals (e.g., catheterization coupled to a source of chemicals and associated pumping mechanism) and that the stimulator itself can be implemented as a chemical delivery device to provide corresponding chemical stimulation.
  • the administration of chemicals to stimulate white matter can be implemented individually, such as an alternative to electrical stimulation, or it can be combined with electrical stimulation of white matter structures in accordance with an aspect of the present invention.
  • electrical and chemical treatments are combined, the same or different delivery mechanisms can be employed to administer the respective chemical and electrical stimulation according to an aspect of the present invention.

Landscapes

  • Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Developmental Disabilities (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une stimulation électrique de structures présentant une densité de fibres élevée, telles que des parties de substance blanche du cerveau, de façon à réaliser une stimulation souhaitée des structures cérébrales associées. La stimulation des parties de substance blanche ou toute autre structure peut réduire les crises épileptiques ou aider à contrôler les crises épileptiques, par surmultiplication d'au moins une activité électrique des structures cérébrales associées.
EP03777727A 2002-10-21 2003-10-20 Stimulation electrique du cerveau Withdrawn EP1556127A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42007902P 2002-10-21 2002-10-21
US420079P 2002-10-21
PCT/US2003/033305 WO2004037342A2 (fr) 2002-10-21 2003-10-20 Stimulation electrique du cerveau

Publications (1)

Publication Number Publication Date
EP1556127A2 true EP1556127A2 (fr) 2005-07-27

Family

ID=32176513

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03777727A Withdrawn EP1556127A2 (fr) 2002-10-21 2003-10-20 Stimulation electrique du cerveau

Country Status (4)

Country Link
EP (1) EP1556127A2 (fr)
AU (1) AU2003286526A1 (fr)
CA (1) CA2502455A1 (fr)
WO (1) WO2004037342A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7403820B2 (en) 1998-08-05 2008-07-22 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US7231254B2 (en) 1998-08-05 2007-06-12 Bioneuronics Corporation Closed-loop feedback-driven neuromodulation
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US9320900B2 (en) 1998-08-05 2016-04-26 Cyberonics, Inc. Methods and systems for determining subject-specific parameters for a neuromodulation therapy
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20080070267A1 (en) * 2004-05-20 2008-03-20 The Regents Of The University Of California Modulation Of Neurotransmitter Activity In Neurons
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US20080027515A1 (en) 2006-06-23 2008-01-31 Neuro Vista Corporation A Delaware Corporation Minimally Invasive Monitoring Systems
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
EP2126785A2 (fr) 2007-01-25 2009-12-02 NeuroVista Corporation Systèmes et procédés d'identification d'un état contre-critique chez un sujet
EP2124734A2 (fr) 2007-01-25 2009-12-02 NeuroVista Corporation Procédés et systèmes permettant de mesurer la prédisposition d'une personne à avoir une crise
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US8340770B2 (en) 2007-06-26 2012-12-25 Durand Dominique M Controlling seizure activity with electrical stimulation
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US20090171168A1 (en) 2007-12-28 2009-07-02 Leyde Kent W Systems and Method for Recording Clinical Manifestations of a Seizure
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
US10589096B2 (en) 2016-04-25 2020-03-17 The Board Of Regents Of The University Of Texas System Systems and methods for network based neurostimulation of cognitive processes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6366813B1 (en) * 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004037342A3 *

Also Published As

Publication number Publication date
CA2502455A1 (fr) 2004-05-06
WO2004037342A3 (fr) 2004-07-01
AU2003286526A1 (en) 2004-05-13
WO2004037342A2 (fr) 2004-05-06

Similar Documents

Publication Publication Date Title
US20050049649A1 (en) Electrical stimulation of the brain
US20240342483A1 (en) Brain stimulation system including diagnostic tool
EP1556127A2 (fr) Stimulation electrique du cerveau
US20240198104A1 (en) Brain stimulation system including multiple stimulation modes
US7742820B2 (en) Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects
US6356788B2 (en) Apparatus and method for adjunct (add-on) therapy for depression, migraine, neuropsychiatric disorders, partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US9042988B2 (en) Closed-loop vagus nerve stimulation
US8000794B2 (en) Method and apparatus for affecting neurologic function and/or treating Neurologic dysfunction through timed neural stimulation
US6205359B1 (en) Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US7974696B1 (en) Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease
US6430443B1 (en) Method and apparatus for treating auditory hallucinations
US20170143966A1 (en) Systems and methods for determining a trajectory for a brain stimulation lead
US20050021104A1 (en) Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20070167991A1 (en) Methods and systems for determining subject-specific parameters for a neuromodulation therapy
JP2009502315A (ja) 摂食障害を治療するための選択的神経刺激
US20050246003A1 (en) Stimulation lead having pairs of stimulating electrodes spaced at different distances for providing electrical stimulation to different nerve tissues
US20230096373A1 (en) Electrical optical medical lead
Morrison Vagus Nerve Stimulation in Epilepsy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050425

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060503